The initial resistance Group K Diagnostics felt among investors seems to be dissipating.
Though at first the Theranos scandal haunted founder Brianna Wronko in the pitch room — one investor even likening her to Theranos CEO Elizabeth Holmes — the founder and CEO says promising results in clinical trials have turned investors onto backing her startup.
On Monday, the company announced it had secured a $2 million Series A aimed at scaling up production, commercialization and regulatory processes for its technology. The funding was led by “a private holding company that asked not to be named,” Wronko said, but like most investors in the round, the firm had previously backed its seed round.
“This was a huge show of support,” said Wronko, who expects the company to be in a new lab space near Jefferson’s campus on 1015 Chestnut St. by January 1. “This is growing us from a small startup to a decent-sized company.”
Group K manufactures a point-of-care testing device for the healthcare space. With a test strip that uses microfluidics technology, a few drops from patient’s blood can be analyzed by a mobile app and yield faster results than traditional analysis. The device and technology, Wronko said, are expected to receive clearance from the Food and Drug Administration by June of next year.
Currently a team of 14 split between Philly and India, the company expects to be at 26 by March next year.
Wronko said it’s the results of the trial, and their transparency toward investors, which have dissipated early skepticism around the company’s technology.
“These are investors who have seen our tech,” the founder and University of Pennsylvania grad said. “We’ve shown them our entire process and we’ve continually given the message that we’re based on science. That’s what’s made a difference. People aren’t comparing us anymore because there wasn’t any technology behind them.”
The Holmes references, she said, have also stopped.
“That’s gone,” Wronko said. “I even have a black T-shirt on today.”
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!